,Generic Drug Name,Generic Manufacturer,Brand Name,Approval Date,
1,DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION USP2 MG/ML; PACKAGED IN20 MG/10 ML AND50 MG/25 MLSINGLE-USE VIALS,SUN PHARMA GLOBAL FZE,DOXIL LIPOSOME INJECTION,2/4/2013,
2,MAFENIDE ACETATE USP FOR 5% TOPICAL SOLUTION50 G STERILE POWDER PER PACKET,PAR FORMULATIONS PRIVATE LIMITED,SULFAMYLON FOR 5% TOPICAL SOLUTION,2/12/2013,
3,FLUDEOXYGLUCOSE F 18 INJECTION USP20-500 mCi/mL @ EOS,HOUSTON CYCLOTRON PARTNERS LP,FLUDEOXYGLUCOSE F18 INJECTION USP,2/14/2013,
4,BUPRENORPHINE HCl AND NALOXONE HCl DIHYDRATESUBLINGUAL TABLETS2 MG (BASE)/0.5 MG (BASE) AND8 MG (BASE)/2 MG (BASE),AMNEAL PHARMACEUTICALS,SUBOXONE SUBLINGUAL TABLETS,2/22/2013,
5,BUPRENORPHINE HCl AND NALOXONE HCL DIHYDRATESUBLINGUAL TABLETS2 MG (BASE)/0.5 MG (BASE) AND8 MG (BASE)/2 MG (BASE),ACTAVIS ELIZABETH LLC,SUBOXONE TABLETS (SUBLINGUAL),2/22/2013,
6,ALENDRONATE SODIUM ORAL SOLUTION70 MG (BASE)/75 ML(ONCE WEEKLY),ROXANE LABORATORIES INC.,FOSAMAX ORAL SOLUTION,2/25/2013,
7,DEXBROMPHENIRAMINE MALEATE & PSEUDOEPHEDRINE SULFATEEXTENDED-RELEASE TABLETS (OTC)6 MG/120 MG,AVANTHI INC.,DRIXORAL COLD AND ALLERGY TABLETS,2/27/2013,
